Next Article in Journal
Unpatterned Bioactive Poly(Butylene 1,4-Cyclohexanedicarboxylate)-Based Film Fast Induced Neuronal-Like Differentiation of Human Bone Marrow-Mesenchymal Stem Cells
Next Article in Special Issue
New Highlights of Resveratrol: A Review of Properties against Ocular Diseases
Previous Article in Journal
Fucoxanthin, a Marine-Derived Carotenoid from Brown Seaweeds and Microalgae: A Promising Bioactive Compound for Cancer Therapy
Previous Article in Special Issue
Lactobacillus paracasei KW3110 Suppresses Inflammatory Stress-Induced Premature Cellular Senescence of Human Retinal Pigment Epithelium Cells and Reduces Ocular Disorders in Healthy Humans
Review

Fucoidans as Potential Therapeutics for Age-Related Macular Degeneration—Current Evidence from In Vitro Research

Department of Ophthalmology, Campus Kiel, University Medical Center Schleswig-Holstein UKSH, 24105 Kiel, Germany
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2020, 21(23), 9272; https://doi.org/10.3390/ijms21239272
Received: 19 November 2020 / Revised: 30 November 2020 / Accepted: 2 December 2020 / Published: 4 December 2020
Age-related macular degeneration (AMD) is the major reason for blindness in the industrialized world with limited treatment options. Important pathogenic pathways in AMD include oxidative stress and vascular endothelial growth factor (VEGF) secretion. Due to their bioactivities, fucoidans have recently been suggested as potential therapeutics. This review gives an overview of the recent developments in this field. Recent studies have characterized several fucoidans from different species, with different molecular characteristics and different extraction methods, in regard to their ability to reduce oxidative stress and inhibit VEGF in AMD-relevant in vitro systems. As shown in these studies, fucoidans exhibit a species dependency in their bioactivity. Additionally, molecular properties such as molecular weight and fucose content are important issues. Fucoidans from Saccharina latissima and Laminaria hyperborea were identified as the most promising candidates for further development. Further research is warranted to establish fucoidans as potential therapeutics for AMD. View Full-Text
Keywords: fucoidan; age-related macular degeneration (AMD); retinal pigment epithelium (RPE); vascular endothelial growth factor (VEGF); Saccharina latissima; Laminaria hyperborea; oxidative stress; sulfated fucan; brown seaweed fucoidan; age-related macular degeneration (AMD); retinal pigment epithelium (RPE); vascular endothelial growth factor (VEGF); Saccharina latissima; Laminaria hyperborea; oxidative stress; sulfated fucan; brown seaweed
Show Figures

Figure 1

MDPI and ACS Style

Dörschmann, P.; Klettner, A. Fucoidans as Potential Therapeutics for Age-Related Macular Degeneration—Current Evidence from In Vitro Research. Int. J. Mol. Sci. 2020, 21, 9272. https://doi.org/10.3390/ijms21239272

AMA Style

Dörschmann P, Klettner A. Fucoidans as Potential Therapeutics for Age-Related Macular Degeneration—Current Evidence from In Vitro Research. International Journal of Molecular Sciences. 2020; 21(23):9272. https://doi.org/10.3390/ijms21239272

Chicago/Turabian Style

Dörschmann, Philipp, and Alexa Klettner. 2020. "Fucoidans as Potential Therapeutics for Age-Related Macular Degeneration—Current Evidence from In Vitro Research" International Journal of Molecular Sciences 21, no. 23: 9272. https://doi.org/10.3390/ijms21239272

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop